| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in operating activities | -1,735 | -1,471 |
| Proceeds from atm | 1,826 | - |
| Proceeds from private placement | 1,375 | 1,375 |
| Issuance costs paid for private placement | -130 | -130 |
| Net cash provided by financing activities | 3,071 | 1,245 |
| Effect of exchange rate changes on cash and cash equivalents | 0 | 0 |
| Net increase (decrease) in cash and cash equivalents | 1,336 | -226 |
| Cash and cash equivalents at beginning of period | 3,232 | - |
| Cash and cash equivalents at end of period | 4,568 | - |
Cyclerion Therapeutics, Inc. (CYCN)
Cyclerion Therapeutics, Inc. (CYCN)